Seroepidemiology of hepatitis C in Kermanshah (West of Iran, 2006)

Hepatitis Monthly

Volumn 8, Issue 2, 2008, Pages 141-146

  Sayad, Babak ^a   Saeed, Fatemeh Shamsedin ^a   Keyvani, Hossein ^b   Rezali, Mansour ^a   Asadi, Tannaz ^a   Vaziri, Siavash ^a   Janbakhsh, Alireza ^a   Mansouri, Feyzollah ^a   Afsharian, Mandana ^a   Laghail, Zahra ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C; Iran; Kermanshah; Seroepidemiology

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DENTISTRY; DRUG DEPENDENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; GENDER BIAS; HEMOPHILIA; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; SEROEPIDEMIOLOGY; TATTOOING; UNSAFE SEX; WESTERN BLOTTING;

EID: 46649097427     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dienstag JL. Chronic viral hepatitis. In: Mandell GI, Bennet JE, Dolin R, eds. Principle and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier 2005: 1441-64.
2. Dienstag JL, Isselbacher KJ. Chronic hepatitis. In: Kasper DL, Braunwald E, Fauci AS, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: Mc Graw-Hill 2005: 1844-55.
3. Thomas DL, Ray SC, Lemon SM. Hepatitis C virus. In: Mandell GI, Bennet JE, Dolin R, eds. Principle and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier 2005: 1950-81.
4. Hamilton BC. Hepatitis C virus. In: Sleisenger P, Fordtan S, eds. Gastrointestinal and Liver Diseases: Pathophysiology, Diagnosis & Management. 1st ed. New York: Academic Press 2002: 1-20
5. Alter MJ, Hutin YJ, Armestrong GL. Epidemiology of hepatitis C. In: Liang TL, Hoofnagle JH, eds. Biomedical Research Reports of Hepatitis C. 1st ed. New York: Academic Press 2002: 169-83.
6. Lidsay KL, Hoofnagle JH. Chronic hepatitis. In: Goldman L, Ausiello D, eds. Cecil Text Book of Medicine. 22th ed. Pennsylvania: Saunders 2004: 921-2.
7. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med 2005; 8: 84-90.
8. Rezvan H, Ahmadi J, Farhadi M, Taroyan S. A preliminary study on the prevalence of anti-HCV amongst healthy blood donors in Iran. Vox Sang 1994; 67: 100.
9. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 2002; 9: 390-2.
10. Sabur B, Borumand P, Mehrabi Y. Evaluation of prevalence rate and distribution of the predisposing factors of hepatitis C in hemodialysis patients in Kermanshah province (1999-2000). Behbood J 2003; 27: 60-6.
11. Hung KYU, Chen WY, Yang CS, Lee S, Wu D. Hepatitis B and C in hemodialysis patients. Dial Transplant J 1995; 24: 135-42.
12. Sabur B, Broumand P, Mehrabi YL. Evaluation of prevalence and distribution of risk factors for hepatitis C in hemodialysed patients at Kermanshah province during 1999-2000. Behbood J 2003; 18: 60-5.
13. Karimi M, Ghavanini AA. Seroprevalence of HBsAg, anti-HGV, and anti-HIV among haemophiliac patients in Shiraz, Iran. Haematologia 2001; 31: 251-5.
14. Perret JL, Moussavou-Kombila JB, Delaporte E, Pemba LF, Boguikouma JB, Matton T, et al. HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study (in French). Gastroenterol Clin Biol 2002; 26: 131-5.
15. Baheti R, Gehlot RS, Baheti R. Seroprevalence of anti HCV Ab in healthy voluntary blood donors and in high risk individuals. J Indian Acad Clin Med 2000; 1: 36-47.
16. Hajiani E, Hashemi J, Masiedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol 2006; 12: 4884-7.
17. Alavian SM, Ahmadzad M, Keshvari M. Efficacy and safety of Interferon-alpha (PDferon B) and Ribavirin combination therapy in patients with chronic hepatitis C in Iran. Hep Mon 2006; 6: 11-8.
18. Alavian SM, Gbolami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17: 1092-7.
19. Saberi-Firoozi M, Yazdankhah S, Karbasi HT. Anti-HCV seropositivity among multiply transfused patients with B-thalassemia major in southern Iran. Irn J Med Sci 1996; 21: 59-67.
20. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology 2003; 8: 256-60.